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5英 汉 缩 略 词 表
英文缩写 英文全称 中文译名
PMOP Postmenopausal osteoporosis 绝经后骨质疏松
HRT Hormone Replacement Therapy 激素替代疗法
OPG Osteoprotegerin 骨保护素
RANKL The receptor activator of nuclear factor
kappa B ligand
细胞核因子 kB 受体








TNF-α The tumor necrosis factor-α 肿瘤坏死因子-α
MDA Malonyldialdehyde 丙二醛
IACUC Institutional Animal Care and Use
Committee
实验动物管理委员
BMD Bone mineral density 骨密度
WHO World Health Organization 世界卫生组织
CA1-25 Carbohydrate antigen 125 癌抗原 1-25




AhR Aryl hydrocarbon receptor 芳香烃受体
OPN Osteopontin 骨桥蛋白
BSP Bone sialoprotein 骨涎蛋白
ER Estrogen Receptor, 雌激素受体
ALP Alkaline phosphatase 碱性磷酸酶
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The prevalence of gynecologic malignant tumors are increasing and the age at
onset has become younger in recent years,which causes a big economic burden and
mental strain to the society and to families.Surgery is the most important treatment
for gynecologic malignant tumors,that supplemented by radiotherapy and
chemotherapy.However,an ovariectomy of both sides and the damage of
radiotherapy and chemotherapy on ovarian will lead to a sharp decline of estrogen,
and the reduction of sex hormones at the time of menopause is known to increase the
risk of osteoporosis. Meanwhile, the adjuvant chemotherapy after surgery may also
induce bone loss which could cause a fracture and seriously affect the patient’s
quality of life.Currently, hormone replacement therapy (HRT) is widely used for
osteoporosis after artificial menopause. Although HRT may lower the rate of
osteoporosis and fracture, large scale clinical research has shown that HRT was a
factor in the growth of ovarian cancer and increased the incidence of breast
carcinoma,cervical carcinoma,endometrial carcinoma,diabetes,cardiovascular
disease, and stroke. Therefore, it is imperative to seek a safer and more effective
therapy that prevents and treat of osteoporosis of gynecological malignant tumor
after artificial menopause.Moreover,olive oil is an integral ingredi-ent of a
Mediterranean diet, and its nutritional, medical, and cosmetic benefits are widely
known and approved.Literature reviews show that in Europe, osteoporosis rarely
happened in the Mediterranean region, as the traditional Mediter-ranean diet always
has a high intake of olive oil.Indeed, olive oil has been used as a folk remedy for
com-bating diseases due to its hypotensive, cardioprotective, antimicrobial,
anti-hyperglycemic, anticancer,improved immunity and anti-inflammatory
pharmacological properties.Therefore, our study will observe effects of olive oil
slow osteoporosis after artificial menopause
Purpose: In vivo experiment: The goal of this study was to investigate the













9rats, and explore its antioxidant, anti-inflammatory properties,regulation of
osteoprotegerin (OPG) and receptor activator of nuclear factor kB ligand (RANKL)
expression in Sprague Dawley rats.While applied olive oil to clinical and to
investigate its anticancer,slowed bone loss properties in patients. In vitro model: To
investigate the effects of olive oil on proliferation of osteoblasts.
Materials and methods: A total of 120 healthy female Sprague Dawley rats
aged 6 months were divided into four groups: 1) sham-operated control (Sham group,
n=30); 2) ovariectomized (OVX group, n=30); 3) ovariectomized rats supplemented
with olive oil (OVX + Olive, n=30); 4) ovariectomized rats supplemented with
estrogen (OVX + E2, n=30). Olive oil and estrogen were administered by oral gavage
at a dose of 5mL/100 g weight (olive oil)and 25μg/kg(E2) on a daily basis for 12
consecutive weeks. Twelve weeks later blood samples were obtained to detect the
levels of calcium(Ca2+), alkaline phosphatase(ALP), phosphorus(P), interleukin-6
(IL-6), malonyldialdehyde (MDA), and nitrate content,osteoprotegerin(OPG),the
receptor activator of nuclear factor kappa B ligand(RANKL).Dual energy X-ray
absorptiometer measured bone mineral density (BMD) of ovariectomized Sprague
Dawley rats that had been fed olive oil for 12 weeks;Blood samples from patients,
who regularly consumed olive oil over a 1 year period were also used to measure
carbohydrate antigen 125, carcino-embryonic antigen, α-fetoprotein, and carbohydrate
antigen 19-9,osteoprotegerin(OPG),the receptor activator of nuclear factor kappa B
ligand(RANKL) levels. BMD of lumbar spine and left femur,BMC and BV were also
evaluated by dual energy X-ray absorptiometry; A total of 20 patients were divided
into control group and experiment group.The experimental group took 50mL of olive
oil daily in the morning with no other medicine or treatment programs, but the control
group took nothing in addition to their regular diet. Both the experimental and control
groups had the same diet. A follow-up telephone call was made each week instructing
the experimental group to take 50mL of olive oil once every morning. All participants
were asked about disease history and each participant received a thorough physical














carbohydrate antigen125, carcino-embryonic antigen, α-fetoprotein, and carbohydrate
antigen 19-9 levels,OPG,RANKL. BMD of lumbar spine (L3、L4)and left femur was
also evaluated by dual energy X-ray absorptiometry.Murine osteoblastic cells were
digested from the skull of newborn SD mice were born in 48 hours,with 0.25%tryp-
sin and 0.1%Ⅱ collagenase. Osteoblasts were alkaline phosphatase staining with
NBT/BCIP kit.Drug stimulation group with concentration of olive oil( 200ul/ml),
estrogen(E2,5μg/ml ) group ,a blank control group. , and Cell proliferation was
tested by CCK8assay.
Results: Animal experiments: ① Compared with OVX group, olive oil and E2
significantly increased BMD of lumbar spine and left femur(P<0.05).While olive oil
and E2 are not different.At the same time olive oil could significantly slow BMC and
BV/TV decreasing (P<0.05);②Compared with OVX group,olive oil decreased levels
of phosphatase, alkaline phosphatase, IL-6, MDA,nitrate and RANKL ,but increased
level of OPG. However, it had no significant effect on the Ca2+ level.Clinical trials:
① Olive oil also significantly improved patients, BMD levels on L3, L4, and left
femoral neck(P<0.05);②Olive oil reduced carbohydrate antigen 125,
α-fetoprotein,carcino-embryonic antigen and RANKL levels,and increased level of
OPG(P<0.05). But it had no significant effect on the carbohydrate antigen 19-9
level.In vitro: Compared with control group,olive oil could facilitate proliferation of
osteoblasts(P<0.05).
Conclusion: Olive oil illustrated significant anti-osteoporosis, antioxidant,
anti-inflammatory, and anticancer properties,increased the level of OPG in serum
anddown regulated the level of RANKL in serum in vivo. However, further studies
are required to determine the active component(s) responsible for these effects.
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